* Acadia Healthcare Company Inc ACHC.OQ ACHC.O is
expected
to show a rise in quarterly revenue when it reports results
* The Franklin Tennessee-based company is expected to
report a
8.8% increase in revenue to $725.315 million from $666.73
million a year ago, according to the mean estimate from 11
analysts, based on LSEG data.
* Refinitiv's mean analyst estimate for Acadia Healthcare
Company
Inc is for earnings of 89 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Acadia
Healthcare
Company Inc is $89, above its last closing price of $73.51.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 0.85 0.86 0.92 Beat 7.5
Mar. 31 2023 0.71 0.71 0.75 Beat 5.8
Dec. 31 2022 0.75 0.75 0.70 Missed -6.6
Sep. 30 2022 0.79 0.79 1.64 Beat 108.5
Jun. 0.78 0.78 0.84 Beat 8
30 2022
Mar. 31 2022 0.64 0.64 0.67 Beat 5.4
Dec. 31 2021 0.68 0.68 0.67 Missed -2
Sep. 30 2021 0.72 0.72 0.72 Met -0.2
This summary was machine generated November 1 at 02:41 GMT. All
figures in US dollars unless otherwise stated